Search

Author/Creator Henry, Keith

1. 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine. (31st December 2020)

Authors:
Brar, Indira; Ruane, Peter; Ward, Douglas; Molina, Jean-michel; Mills, Anthony; Berhe, Mezgebe; Brinson, Cynthia; Rampogal, Moti; Benson, Paul; Henry, Keith; Huang, Hailin; Andreatta, Kristen; Martin, Hal
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S543
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. (31st December 2020)

Authors:
Smith, Graham; Henry, Keith; Podzamczer, Daniel; Masiá, Mar; Bettacchi, Christopher; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Sutton, Kenneth; Zhang, Feifan; McCoig, Cynthia C; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Spreen, William; Margolis, David
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S379
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. (1st June 2017)

Authors:
Raffi, François; Orkin, Chloe; Clarke, Amanda; Slama, Laurence; Gallant, Joel; Daar, Eric; Henry, Keith; Santana-Bagur, Jorge; Stein, David K.; Bellos, Nicholaos; Scarsella, Anthony; Yan, Mingjin; Abram, Michael E.; Cheng, Andrew; Rhee, Martin S.
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 75:Number 2(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us. Issue 1 (January 2013)

Authors:
Buchacz, Kate; Baker, Rose K; Palella, Frank J; Shaw, Lauren; Patel, Pragna; Lichtenstein, Kenneth A; Chmiel, Joan S; Vellozzi, Claudia; Debes, Rachel; Henry, Keith; Overton, E Turner; Bush, Timothy J; Tedaldi, Ellen; Carpenter, Charles; Mayer, Kenneth H; Brooks, John T
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 1(2013)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine. Issue 4 (August 2015)

Authors:
Young, Benjamin; Squires, Kathleen E.; Tashima, Karen; Henry, Keith; Schneider, Stefan; LaMarca, Anthony; Zhao, Henry H.; Ross, Lisa L.; Shaefer, Mark S.
Journal:
HIV clinical trials
Issue:
Volume 16:Issue 4(2015)
Page Start:
125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine. Issue 4 (August 2015)

Authors:
Young, Benjamin; Squires, Kathleen E.; Tashima, Karen; Henry, Keith; Schneider, Stefan; LaMarca, Anthony; Zhao, Henry H.; Ross, Lisa L.; Shaefer, Mark S.
Journal:
HIV clinical trials
Issue:
Volume 16:Issue 4(2015)
Page Start:
125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. (1st November 2021)

Authors:
Fajnzylber, Jesse; Sharaf, Radwa; Hutchinson, John N.; Aga, Evgenia; Bosch, Ronald J.; Hartogensis, Wendy; Jacobson, Jeffrey M.; Connick, Elizabeth; Volberding, Paul; Skiest, Daniel J.; Margolis, David; Sneller, Michael C.; Little, Susan J.; Gulick, Roy M.; Mellors, John W.; Gandhi, Rajesh T.; Sc...
Journal:
AIDS
Issue:
Volume 35:Number 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection. (8th September 2016)

Authors:
Borges, Álvaro H.; Neuhaus, Jacqueline; Babiker, Abdel G.; Henry, Keith; Jain, Mamta K.; Palfreeman, Adrian; Mugyenyi, Peter; Domingo, Pere; Hoffmann, Christian; Read, Tim R. H.; Pujari, Sanjay; Meulbroek, Michael; Johnson, Margaret; Wilkin, Timothy; Mitsuyasu, Ronald
Journal:
Clinical infectious diseases
Issue:
Volume 63:Number 12(2016)
Page Start:
1668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

Authors:
Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason...
Journal:
Lancet
Issue:
Volume 8:Issue 7(2021)
Page Start:
e397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study. Issue 4 (April 2015)

Authors:
Molina, Jean-Michel; Clotet, Bonaventura; van Lunzen, Jan; Lazzarin, Adriano; Cavassini, Matthias; Henry, Keith; Kulagin, Valeriv; Givens, Naomi; de Oliveira, Carlos Fernando; Brennan, Clare
Journal:
Lancet
Issue:
Volume 2:Issue 4(2015)
Page Start:
e127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗